Susquehanna International Group’s Innovator IBD ETF Leaders ETF LDRS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q3 | – | Sell |
-30,912
| Closed | -$860K | – | 14082 |
|
|
2021
Q2 | $860K | Buy |
+30,912
| New | +$850K | ﹤0.01% | 8180 |
|
|
2021
Q1 | – | Sell |
-36,204
| Closed | -$1.04M | – | 13149 |
|
|
2020
Q4 | $1.04M | Buy |
+36,204
| New | +$969K | ﹤0.01% | 6650 |
|
|
2020
Q2 | – | Sell |
-41,749
| Closed | -$777K | – | 11323 |
|
|
2020
Q1 | $777K | Buy |
41,749
+7,497
| +22% | +$160K | ﹤0.01% | 5954 |
|
|
2019
Q4 | $772K | Buy |
34,252
+23,513
| +219% | +$521K | ﹤0.01% | 6039 |
|
|
2019
Q3 | $236K | Sell |
10,739
-17,954
| -63% | -$393K | ﹤0.01% | 8783 |
|
|
2019
Q2 | $609K | Buy |
+28,693
| New | +$606K | ﹤0.01% | 6855 |
|
|
2019
Q1 | – | Sell |
-59,582
| Closed | -$1.27M | – | 10241 |
|
|
2018
Q4 | $1.27M | Sell |
59,582
-7,294
| -11% | -$167K | ﹤0.01% | 4249 |
|
|
2018
Q3 | $1.7M | Buy |
66,876
+26,593
| +66% | +$675K | ﹤0.01% | 4267 |
|
|
2018
Q2 | $1.01M | Sell |
40,283
-4,280
| -10% | -$106K | ﹤0.01% | 5328 |
|
|
2018
Q1 | $1.1M | Buy |
+44,563
| New | +$1.14M | ﹤0.01% | 5048 |
|
Susquehanna International Group's LDRS Position: Q3 2021 in Review
Susquehanna International Group sold out of Innovator IBD ETF Leaders ETF (LDRS) in Q3 2021, closing a stake of 30,912 shares — an estimated $860K sold.
Susquehanna International Group first reported a position in LDRS in Q1 2018 and held it in 10 quarters. The position peaked at $1.7M in Q3 2018. 0 funds tracked by Wall St. Rank hold LDRS as of Q3 2021.
- Susquehanna International Group reported no remaining Innovator IBD ETF Leaders ETF position as of Q3 2021 after selling out during the quarter.
- Susquehanna International Group sold 30,912 Innovator IBD ETF Leaders ETF shares in Q3 2021, an estimated $860K.
- Susquehanna International Group first reported a position in Innovator IBD ETF Leaders ETF in Q1 2018 and held it in 10 quarters.
- Susquehanna International Group's Innovator IBD ETF Leaders ETF position peaked at $1.7M in Q3 2018.
- 0 funds tracked by Wall St. Rank held Innovator IBD ETF Leaders ETF as of Q3 2021.
Based on Susquehanna International Group's 13F filing for Q3 2021, filed 15 Nov 2021.